Tnfr
Home Site Map

New Immune Approach for Treatment of Alzheimer's Disease
New hope for a much needed new approach for tackling Alzheimer's disease will be discussed in detail this week at a new medical conference in Philadelphia. At the inaugural Targeting Alzheimer's with Novel Therapeutics conference, to be held as part of the 8th annual World Pharmaceutical Congress, Edward Tobinick MD, Director of the Institute for Neurological Research, a private medical group, inc. in Los Angeles, will present the latest data on a revolutionary new immune approach for treatment of Alzheimer's disease.

Scientist at The Fienstein Instute for Medical Research Discovers Quitting Smoking Promotes Anti-Inflammatory Response
Christine Metz, PhD, is a scientist at The Feinstein Institute for Medical Research who is trying to identify some of the factors that play into a smoker's decision to quit.

Nemours Center for Childhood Cancer Research Receives Over $1 Million in Grants for Cancer Research in 2008
The research team at the Nemours Center for Childhood Cancer Research (NCCCR), a newly established division of Nemours Biomedical Research headquartered at the Alfred I. duPont Hospital for Children in Wilmington, DE, has secured $1,020,000 in external funding for awards starting in 2008 and 2009.

Rheumatoid Arthritisý Is Gene Therapy the Answer?
Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis affecting approximately 21 million Americans

Tnfr

Spinal Surgery a Risk for Tiger
Tiger Woods neck injury: Can it threaten his golf career? Tiger's withdrawal from The Players Championship due to a neck injury has caused media speculation on how this might affect his career. What are the facts? The media descriptions suggest that inflammation of a spinal nerve in the neck due to damage to an intervertebral disc is the most likely diagnosis. The medical term is "cervical radiculopathy". While spontaneous improvement without treatment is a possibility, Tiger may also face the risk of spinal surgery. Non-surgical treatments, such as injections with cortisone or a newer more selective anti-inflammatory that blocks TNF (a treatment method developed at the INR® in Los Angeles), are other possibilities. With ...

Global Rheumatoid Arthritis Therapeutics Market to Exceed $23.12 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
GIA announces the release of a comprehensive global report on Rheumatoid Arthritis Therapeutics markets. The world market for rheumatoid arthritis biologic therapeutics is projected to exceed $23.12 billion by 2015. The market comprises of a sizeable, growing patient population encompassing untreated patients, patients taking DMARDs, patients taking anti-TNF therapies, and patients taking non-anti-TNF therapies. Among all therapies, anti-pro-inflammatory drugs that block the action of TNF-alpha (known as anti-TNF biologics) dominate the market.

What is Inflammatory Arthritis and Why do People With This Problem Fail Treatment?
The term 'inflammatory arthritis? refers to a number of conditions where there is obvious inflammation of the joint Sometimes the diagnosis is known? an example would be a patient with classic rheumatoid arthritis (RA)




Privacy Policy | Copyright/Trademark Notification